CARDLYTICS, INC. (CDLX) Return on equity 2018–2024
CARDLYTICS, INC. (CDLX) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-270.5%FY2024 · since FY2018: -102.1% → -270.5%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -270.5% | -170.5 pp |
| FY2023 | -99.9% | +119.9 pp |
| FY2022 | -219.9% | -201.3 pp |
| FY2021 | -18.6% | +16.6 pp |
| FY2020 | -35.3% | -23.3 pp |
| FY2019 | -12.0% | +90.1 pp |
| FY2018 | -102.1% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice